Clover Corporation Limited (ASX:CLV)
Clover Corporation Ltd (ASX:CLV) is involved in the delivery of stable omega-3 and omega-6 products in the infant nutrition and medical foods market. Founded in 1988 and listing on the ASX in 1999, Clover initially began as a research & development and marketing company. It is now committed to delivering “next-generation infant nutrition” through its microencapsulation technology.
Clover Corporation Limited (ASX:CLV) share price
Clover Corporation Limited (ASX:CLV) passive income
Clover Corporation Limited (ASX:CLV) share price news
S&P/ASX 200 (INDEXASX:XJO) down: QBE Insurance Group (ASX:QBE) rallies on good guidance
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.76% to 6,987.60.
Why WHSP (ASX:SOL) could be the best ASX dividend share
Washington H. Soul Pattinson and Co. Ltd (ASX:SOL) could be the best ASX dividend share, and I’m going to tell you why.
HY21 result impresses, Clover (ASX:CLV) share price up
The Clover Corporation Limited (ASX:CLV) share price is up 7% after the business reported its FY21 half-year result (HY21).
FY20 result: Clover reports more strong growth, time to buy shares?
Clover Corporation Limited (ASX:CLV) has reported its FY20 result to investors, showing more strong growth.
ASX infant formula wars: a2 Milk vs. Bubs vs. Nuchev
Let’s take a look three ASX infant formula shares at different stages of their growth journies: a2 Milk (ASX:A2M), Bubs Australia (ASX:BUB) and Nuchev (ASX:NUC).
Why the Clover (ASX:CLV) share price is rocketing
The Clover (ASX:CLV) share price is currently up 13% after the company gave an update.
Soul Pattinson (SOL) Profit Pops, Dividends Up
This morning, Washington H. Soul Pattinson & Co. Ltd (ASX: SOL) (“Soul Pattinson”), the conglomerate ‘holding’ company, released its half-year financial report to the ASX.